HLS 3.38% $1.38 healius limited

RACGP is an influential group and this response likely to have...

  1. 43 Posts.
    lightbulb Created with Sketch. 6
    RACGP is an influential group and this response likely to have some weight.

    https://www.racgp.org.au/advocacy/reports-and-submissions/view-all-reports-and-submissions/2023-reports-and-submissions/racgp-response-to-accc-review-of-the-merger

    HomeAdvocacyReports andsubmissionsView allreports and submissions2023 reports andsubmissionsRACGPresponse to ACCC review of the merger between Australian Clinical Labs Limitedand Healius Lim

    Date: 29 May2023

    The RACGP hasresponded to the Australian Competition and Consumer Commission (ACCC) reviewof the merger between Australian Clinical Labs Limited (ACL) and HealiusLimited (Healius). The RACGP letter highlights the potential impacts of thismerger on access to healthcare for patients across Australia.

    Readthe submission.Letter to ACCC re Pathology Merger- 29 May 2023 (PDF)

 
watchlist Created with Sketch. Add HLS (ASX) to my watchlist
(20min delay)
Last
$1.38
Change
0.045(3.38%)
Mkt cap ! $998.3M
Open High Low Value Volume
$1.35 $1.38 $1.33 $3.765M 2.758M

Buyers (Bids)

No. Vol. Price($)
37 146122 $1.37
 

Sellers (Offers)

Price($) Vol. No.
$1.38 37960 1
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
$1.37
  Change
0.045 ( 3.10 %)
Open High Low Volume
$1.34 $1.38 $1.33 1791362
Last updated 15.59pm 06/06/2024 ?
HLS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.